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WG1. General principles. Technical aspects. Radiation safety 
 
 
1. Radiological imaging techniques are complementary to endoscopic assessment. Cross-
sectional imaging offers the opportunity to detect and stage inflammatory, obstructive and 
fistulising CD and is fundamental at first diagnosis to stage disease and to monitor follow-up 
(EL:1a; RG:A). 
 
The diagnosis of Inflammatory Bowel Disease (IBD) is based on a combination of endoscopic, histological, 
radiological, and/or biochemical investigations as a single gold standard is missing (1). For suspected IBD, 
ileocolonoscopy and biopsies from the terminal ileum as well as from each colonic segment are the first 
line procedures to establish the diagnosis (1). Crohn’s disease (CD) may affect segments of the small bowel 
beyond the reach of ileocolonoscopy, may hamper the advance of the scope due to strictures or may be 
complicated by extra-mural manifestations of the intestine or in the perineal region (including fistulas and 
abscesses) not amenable to endoscopic visualisation. Thus, cross-sectional imaging  techniques are an 
important adjunct to endoscopic assessment, to allow a complete and sensitive staging of the small bowel 
and perineum with the unique advantage to assess mural and extramural disease (2).  
The applications of cross-sectional imaging techniques in IBD are manifold. In cases of suspected CD cross-
sectional imaging of the small bowel is recommended to detect, stage and classify disease behaviour(1, 2). 
In established CD it assists to select treatment, to assess response and to quantify tissue damage (2, 3). In 
perianal fistulising CD it complements the examination under anaesthesia by an experienced surgeon. In 
suspected ulcerative colitis (UC) with a discontinuous endoscopic appearance of colonic inflammation 
cross-sectional imaging should be considered to exclude small bowel inflammation indicating the 
differential diagnosis with CD (1).  
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2a. US is a well-tolerated and radiation-free imaging technique, particularly for the terminal 
ileum and the colon. Examinations are impaired by gas-filled bowel and by large body habitus. 
EL:2, RG:B 
US is also a technique to guide interventional procedures (e.g., abscess drainage) (EL2a;RGB) 
 
 
Ultrasound (US) is non-invasive, does not impart ionising radiation, and is well tolerated and accepted by 
patients. Bowel examination may be hampered by air, the volume of which may be reduced by 
recommending the patient to fast at least 6 hours before the examination. The use of laxative and non-
flatulent preparations is not required before routine abdominal ultrasound(4) . 
Specific preparations with the oral administration of intraluminal contrast can improve image quality and 
diagnostic accuracy (5). Oral intake is generally better accepted by patients than techniques using small 
bowel intubation, and non-absorbable fluid should be used to reduce the volume needed.(5) 
US for IBD requires high-frequency (5-17 MHz) linear array probes to increase spatial resolution and to 
allow adequate assessment of bowel diameter and of the recognisable 5-layer wall pattern (6). A 
systematic approach to search for intestinal wall abnormalities is recommended including four scanning 
positions in the upper and lower, right and left abdominal quadrants. . The ileocecal region, sigmoid and 
often ascending and descending colon are adequately visualised in most patients. The proximal ileum and 
jejunum can be difficult to assess due to multiple overlying bowel loops and deep pelvic location, whereas 
the study of transverse colon is challenging because of its variable anatomy, and the rectum for 
accessibility. 
Contrast-enhanced US (CEUS)may improve diagnostic accuracy and diagnostic confidence in detecting 
inflammatory activity (7, 8). 
Ultrasound is a validated technique to guide interventional procedures. For example percutaneous or 
transrectal abscess drainage under sonographic guidance has an high technical success rate of 96% (9-11). 
Moreover, ultrasound can be useful to detect and drain  pyogenic liver abscess.(10) (12) and is also suitable 
to guide insertion of intravenous lines, particularly in paediatric patients.(13). 
Demonstration and communication of the extent of abnormality and comparison between studies at 
clinical/radiology/nuclear medicine conference is generally easier with other imaging modalities, such as 
computed tomography (CT) and magnetic resonance imaging (MRI). 
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2b. CT of the abdomen and pelvis in order to assess the small intestine and colon requires 
luminal distension, and intravenous contrast administration. Radiation exposure is the major 
limitation. CT can be used to guide interventional procedures (e.g. abscess drainage). 
(EL:2a;RG:B) 
 
CT of the small intestine and colon is performed using a multidetector-row scanner able to cover the 
required anatomical region within a single breath-hold. Rapid image acquisition minimizes motion and 
peristaltic artefacts. Imaging protocol includes thin detector collimation and slice thickness (in order to 
benefit from multiplanar reformats) (14-16).  
The use of intravenous injection of contrast medium is important for the assessment of bowel wall 
enhancement pattern and mesenteric vessels (15, 17, 18). Bowel distension is a fundamental requisite for 
any imaging method of the small intestine, since collapsed bowel loops can either hide lesions or simulate 
pathological wall thickenings (19-21). Luminal distension can be achieved with enteric contrast agents, 
either positive or neutral. Neutral contrast agents, which possess X-ray attenuation similar to water, are 
preferred for most of the clinical indications (22-24).  To minimize absorption, water is usually mixed with 
high molecular sizes compounds which do not alter water density and taste, such as polyethylene glycole 
(PEG), mannitol, sugar alcohols or sorbitol. Positive contrast agents are usually a mixture of barium 
sulphate (1-2%) or iodinated contrast agents (2-3%). In IBDs positive enteral agents are preferred for the 
evaluation of perforations or fistulas (25, 26). 
Enteric contrast agent can be administered orally (CT enterography) or injected through a naso-jejunal tube 
(CT enteroclysis).  CT enterography is faster, less demanding for radiologists and has superior patient 
acceptance compared with enteroclysis . CT enterography provides good distension of mid-terminal ileum, 
but offers limited distention of the jejunum (24). Diagnostic performances are similar in CD, although CT-
Enteroclysis has higher specificity, but also a slightly higher radiation burden because of the additional 
exposure associated with nasojejunal tube placement under fluoroscopy guidance (24).  
Radiation exposure is the major limitation of CT, particularly in patients underoging repeated examinations 
(27, 28). The use of new dose reduction techniques, like adaptive statistical iterative recostruction, should 
be recommended especially in younger patients (27, 28). 
 
CT is also usefull to guide interventional procedures such as percutaneus drainage of intrabdominal abscess 
or pyogenic liver abscess. (10). Although  use of surgery remains common in such patients, , radiologically 
(CT) guided nonsurgical therapy is of increasing importance.  .(29-33).  
 
 European evidence-based consensus on the use of imaging techniques in IBD diagnosis & management  (1.9.1)   5 
 
 
2c. MRI of the small bowel and colon requires fast imaging techniques and luminal distension 
[EL1;RGB].MR enterography/enteroclysis (MRE) has similar diagnostic accuracy and similar 
indications to CT, but with the major advantage of not imparting ionising  radiation [EL:2a;RG:B]. 
 
MRI of the small bowel and colon requires fast sequences, able to acquire T1- and T2-weighted images 
within a single breath hold, and limiting motion and peristaltic artefacts [19-23. The use of intravenous 
injection of contrast medium is mandatory for the assessment of bowel wall enhancement pattern and 
mesenteric vessels. 
Diffusion-weighted imaging is feasible in CD, even without bowel preparation, and has utility infor 
detecting colonic inflammation (34, 35) . The inclusion of small bowel motility evaluation may increase 
lesion detection rate compared with static MRE alone (36, 37). 
Similarly to CT,  enteric contrast agent can be administered orally (MR enterography) or injected through a 
naso-jejunal tube (MR enteroclysis) (38). Enteric contrast agents can be classified according to the action on 
the signal intensity of bowel lumen into positive, negative and biphasic agents. The use of positive agents 
has been largely abandoned, and currently both biphasic and negative contrast agents are widely used (39). 
Biphasic contrast agents include several non-absorbable iso-osmolar solutions [poly-ethylene glycol or 
mannitol solutions], which produce a negative effect on T1-weighted and a positive effect on T2-weighted 
images (‘‘water-like’’ effect), providing satisfactory dilation of the small bowel without side effects, 
excluding mild laxation. Negative contrast agents, made of a superparamagnetic non-absorbable solution 
of iron oxide particles, markedly reduce the signal of the intestinal lumen, both on T1 and T2 weighted 
images (‘‘black lumen’’ effect) (40-43). 
Pelvic MRI using high resolution T2-weighted images and contrast-enhanced T1-weighted images is the 
imaging modality of choice for the evaluation of perianal disease, fistula, and adjacent abscesses; it is 
superior to anal endosonography, CT or surgical evaluation for showing disease extent (44, 45). 
CT and MRI have a similar diagnostic accuracy for imaging IBD (46, 47). CT has greater availability and is less 
time consuming than MRI.  
 
2d. NM procedures especially WBC scintigraphy are an alternative to cross-sectional imaging for 
evaluation of disease activity and extension in specific situations (EL2 GR B). Radiation exposure 
is the major limitation. PET/CT with FDG is poorly specific for inflammation and for assessing 
disease activity (EL:3, GR:D) 
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Scintigraphy with radiolabelled  leukocytes (WBS) is useful in the diagnosis of IBD, and in particular  to 
evaluate disease extension and activity (48-57). A normal scan makes the presence of active IBD very 
unlikely (48-57). WBC scintigraphy explores the whole intestine in a single image and with  relatively  low 
radiation exposure(2-4 mSv /exam)  (58)so may be particularly suited to the investigation of  children (52, 
59) . 
WBC scintigraphy has demonstrable utility in follow up and for evaluating response to treatment, 
particularly in patients with UC (49, 51). After surgery, it can be used to differentiate between disease 
relapse and fibrotic tissue (60, 61).  
In some countries WBC scintigraphy is substituted with the anti-granulocyte monoclonal antibody 
scintigraphy, that, however, showed less sensitivity and specificity for IBD (48). 
The role of PET/CT with FDG has not yet been clearly established (62-64). 
 
2e. Small bowel follow-through (SBFT) and enteroclysis (SBE), have high accuracy for mucosal 
abnormality and are widely availabile., They are less able to detect extramural complications and are 
contraindicated in high grade obstruction and perforation. Radiation exposure is a major limitation 
EL:2b, RG:B 
 
Barium contrast examinations are long established for small bowel evaluation and are in widespread use  
(65) using either a SBFT or SBE techniques. SBFT may be augmented by pneumocolon to produce double 
contrast imaging (66). SBE is inherently more invasive with tube placement resulting in a higher radiation 
exposure compared with SBFT (67). Although the radiation exposure for barium studies is lower than for 
CT, it is nevertheless a significant exposure for adults (68) and children (69) particularly where repeated 
examinations are performed. Moreover, excessive fluoroscopy time and number of abdominal radiographs 
can result in actual doses that are equivalent to CT (69).  Both techniques have acceptable accuracy in the 
depiction of strictures and ulceration related to CD compared with other techniques (70-72) and to date 
have acted as a benchmark for comparison with other modalities(46). Direct comparison indicates 
superiority of SBFT over SBE for detection of mucosal detail and fistula (73). Extramural complications 
including internal fistulas may be identified (74) but other extramural complications such as abscess are not 
reliably demonstrated compared with other modalities (75). Wide availability and low cost are advantages 
but barium is contraindicated in high-grade obstruction and bowel perforation, which limits the role of this 
modality in patients with acute presentation. While other imaging modalities have advantages, SBFT 
remains an acceptable method of small bowel assessment where access to other techniques is limited.  
 
2f. Plain films have a role in the assessment of specific emergency cases. [EL:3B; RG:C]  
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Plain abdominal radiographs have been routinely used in the assessment of patients with IBD for many 
years. However the status of plain film radiography in the triage of patients with the acute abdomen is 
diminishing in favour of ultrasound and CT (76) particularly with the development of low dose CT 
techniques  (77, 78). Data on the accuracy of plain films is limited to small series. Furthermore conclusions 
are conflicting both in terms of accuracy for assessment of the distribution and severity of colitis (by 
assessment of the extent of faecal residue, dilatation and wall thickening) (79-81) and for locating and 
defining the aetiology of small bowel obstruction (by detection of small bowel dilatation)(82-84).  Plain 
abdominal and chest radiographs may detect perforation but cannot determine the cause and have a lower 
sensitivity than CT for abscess and intra-abdominal free gas (85, 86).  
Plain films have no role in the routine assessment of non-emergency clinical presentations due to their 
failure to  to adequately assess the distribution or activity of disease.  Where out of hours access to other 
imaging modalities services is limited, plain films can help direct clinical decision-making in the acute 
setting.  However where findings are equivocal, other more accurate imaging modalities should be used, in 
particular where radiographs fail to demonstrated abnormality in a patient with high clinical suspicion of an 
acute abdominal complication related to known IBD. 
  
 
 3. High radiation exposure and earlier age of exposure both increase the risk of radiation-
induced cancer. [EL:2b; RG:B]. 
Independent predictors of increased radiation exposure in IBD patients are: diagnosis of CD, 
need of steroids, IBD related surgery, increasing severity, upper gastrointestinal tract 
involvement, the first year following diagnosis and young age of disease onset [EL:2B; RG:B]. 
 
Repeated CT examinations, particularly in children and young patients, may expose those individuals to an 
increased life-time radiation-induced cancer risk (87, 88). The chronically progressive nature of IBD which 
results in intestinal damage, hospitalisations, surgery and the screening for infections or disease 
complications determines higher levels of annual and total diagnostic radiation exposure particularly due to 
use of CT in patients with CD and UC (89). Patients with CD have a higher cumulative radiation exposure 
than patients with UC (90). According to a recent meta-analysis the pooled prevalence of IBD patients 
receiving potentially harmful levels of radiation (defined as ≥50 milli-Sieverts, mSv), was 8.8% (11.1% and 
2% for CD and UC, respectively). IBD-related surgery and corticosteroid use were significant risk factors 
with pooled adjusted odds ratio of 5.4 (95% CI 2.6-11.2) and 2.4 (95% CI 1.7-3.4) respectively (91). Other 
factors noted to be associated with a high cumulative effective dose were age <17 years at diagnosis, the 
first year after diagnosis, upper gastrointestinal tract disease, penetrating disease, use of infliximab and 
multiple surgeries (16, 92). 
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In clinical practice the appropriateness of CT use should be scrutinised, particularly in young patients and 
when alternative modalities with acceptable accuracy are available (88).  
Low-dose CT examinations (<2 mSv) are now possible due to the development of new techniques based 
adaptive statistical iterative reconstruction method. Iterative methods allow significant radiation dose 
reduction without sacrificing image quality as compared with filtered back projection alone (14, 28, 93). 
Unfortunately availability is still currently limited to a few diagnostic centres (2, 28), although as 
dissemination occurs, the role of CT in IBD may be reviewed . 
 
 
 
4. CT, US and SBFT are generally more available and less expensive than MRI and scintigraphy 
EL:5, RG:D 
 
Availability of equipments and expertise of interpreting personnel are generally greater  for CT, US and 
SBFT in comparison with MRI and WBC scintigraphy. The major limitation of WBC scintigraphy is the limited 
availability. 
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WG2: Upper GI tract  & small bowel  
 
 
Small bowel enteroclysis (SBE) and small bowel follow-through (SBFT) 
Historically, SBE and SBFT examinations have been the standard radiologic approaches used to assess 
patients with suspected or established CD. Radiologic findings include irregular thickening and alteration of 
the circular folds, narrowing of the bowel lumen with presence of ulcerations, loop adhesions or separation  
because of wall thickening and mesenteric inflammatory infiltration (94). 
SBE has been shown to be highly accurate, with 95% sensitivity and 96.5% specificity in diagnosing small 
bowel disease using ME enteroclysis as reference standard (95). In severe cases of CD with clinical suspicion 
of septic complications such as abdominal mass or fever, the accuracy of SBE for detecting internal fistulas 
and intra-abdominal abscesses, , was 80.3% against a reference standard of intraoperative findings . (74).  
Some investigators have compared SBFT with SBE studies and reported comparable results (96). In a 
prospective study, it was concluded that SBFT is safer, preferred by patients, and  is less likely to  miss 
gastroduodenal disease compared to SBE. A normal SBFT obviated the need to perform SBE (73). However, 
other researches have suggested that SBE is more accurate than SBFT at detecting early mucosal lesions 
(97-99).  Both methods provide only limited and indirect information in regard to the state of the bowel 
wall and extraluminal extension of CD. Although barium imaging manages to accurately detect the location 
and extension of CD, it is not as accurate as other radiologic imaging modalities in providing information on 
extraluminal manifestations (75, 98). 
 
Ultrasound 
US diagnosis of CD relies on several features, but primarily on the detection of increased bowel wall 
thickness, which is considered the most common and constant US finding in CD (100). The importance of 
5. SBE, SBFT, US, CT, MRI and WBC scintigraphy are able to detect signs of Crohn’s disease [EL 
2b, Gr B] US, CT, and MRI have a high and comparable diagnostic accuracy at the initial 
presentation of terminal ileal CD. [EL:1b, RG:A]. SBE and SBFT have an acceptable accuracy for 
mucosal disease but are less accurate for mural disease and extramural complications. [EL:3b, 
RG:C]  
6. US, CT, MRI and WBC scintigraphy can be used to assess disease activity in Crohn’s disease of 
the terminal ileum [EL:1a, RG:A]. MRI; CT and WBC scintigraphy are able to explore the entire 
length of the small bowel whereas US has a more limited coverage. [EL5, RG:D] 
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this sign for the accuracy of US diagnosis of CD has been evaluated in several studies and sensitivities of 
75–94% with specificities  of 67–100% have been reported (101-103). In a meta-analysis of seven 
prospective and appropriately designed studies (five case control and two cohort studies), it was shown 
that when >3 mm cut-off level was applied for abnormality, the sensitivity and specificity of US in the 
diagnosis of CD were 88 and 93%, whilst when a cut-off level of >4 mm was used, sensitivity was 75% and 
specificity 97%(104). In a recent systematic review (35), the overall per-patient sensitivity of US for the 
diagnosis of CD was 85% (95% CI 83–87%). Overall per patient specificity derived from studies reporting this 
metric was 98% (95% CI 95–99%). 
The use of intraluminal orally administered contrast agents, such as iso-osmolar polyethylene glycol 
solution at a dose ranging from 500 to 800 ml, has also been proposed to better define CD. Whilst  the use 
of intraluminal contrast appears to reduce intraobserver variability and increase sensitivity in defining 
disease extension, location and intestinal complications in patients with established CD, its value in the 
early diagnosis of CD has not been proven (105, 106). 
 
Computed tomography 
The accuracy of CT (either CT enteroclysis or CT enterography) for diagnosing of CD in patients with a 
suspected diagnosis has been investigated in several prospective studies. A good correlation  has been 
shown between CT and histopathology results in regards to inflammatory changes (Spearman's r = 0.7, P < 
0.0001), but no details were provided for signs of fibrostenosis (107). CT variables associated with 
inflammation were mucosal enhancement, wall thickness, comb sign, and presence of enlarged lymph 
nodes (P values 0.04, 0.04, <0.0001, and 0.016, respectively). Solem et al. reported the results of a 
prospective, blinded randomized controlled trial that compared the utility of four primary small- bowel 
imaging modalities: CT, ileocolonoscopy, capsule endoscopy (SBCE) and SBFT as diagnostic tools for CD. The 
researchers aimed to administer all four tests to 41 patients with known or suspected small-bowel CD over 
a 4-day period (72). Of the 41 patients enrolled, only 26 underwent all four tests. Sensitivity was not 
significantly different between the techniques (83% for SBCE, 67% for CT and ileocolonoscopy, and 50% for 
SBFT). Specificity was significantly lower in SBCE (53%) than in all other tests (100%, P <0.05 for all). The 
authors concluded that a combination of at least two diagnostic techniques (preferably ileocolonoscopy 
plus CT) should be implemented as first-line diagnostic assessment of small-bowel CD. In addition small 
bowel radiological imaging, preferably using CT or MRI, is needed prior to SBCE because of the high 
frequency of asymptomatic stenosis in suspected or known CD patients, risking capsule retention, and 
because these techniques can also detect extraluminal complications (72, 108, 109) .  
  
Magnetic Resonance Imaging 
MRI allows for an accurate assessment of the small bowel without radiation exposure, making this imaging 
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tool ideally suited to the CD population given their age and need for repeated imaging.  
MRI changes associated with the presence of inflammation include wall thickening, wall hyper-
enhancement after injection of MRI contrast medium, presence of wall oedema, and presence of ulcers, as 
well as extramural changes such as presence of comb sign, fat stranding and enlarged lymph nodes (110). A 
systematic review reported per-patient sensitivity and specificity of MRI for the diagnosis of CD as 78% 
(95% CI 67–84%) and 85% (95% CI 76–90%) respectively (35).  
 
Nuclear Medicine 
NM imaging provides information about the presence of an inflammatory process in the small and large 
bowel as well as its extent (57). Leukocytes are labelled in vitro, using 99mTc-HMPAO or 111In-oxine, and is 
considered to entail a low radiation exposure. 99mTc-HMPAO is the first option due to the highest 
availability and lower radiation burden (111). The accumulation of labelled leukocytes identifies the 
presence of active disease within the bowel or other complications such as fistulae or abscess (94, 95). 
FDG-PET/CT might be used for early therapy follow-up particularly in non-complicated IBD eligible for 
biological treatment. Nevertheless, while preliminary literature data suggest that PET/CT with FDG has a 
clinical value in adults and paediatric patients, there is at present not enough evidence to support its use in 
clinical practice (48, 62, 63, 111, 112).  
 
Comparison of SBE, SBFT, US, CT, MRI and NM 
In a recent study, SBFT, CT and MRI were compared and appeared to be equally accurate in the 
identification of active inflammation in the small intestine. Although the sensitivity values of CT (89%) and 
MRI (83%) were slightly higher than those of SBFT (67%–72%) with regard to active terminal ileitis, these 
differences were not significant (75). 
A meta-analysis comparing the accuracies of US, MRI, scintigraphy, CT, and PET for diagnosis in patients 
with suspected or known IBD, mainly CD, (46), showed that mean sensitivity estimates for the diagnosis of 
IBD on a per-patient basis were high and not significantly different among the imaging modalities (90%, 
93%, 88%, and 84% for US, MRI, scintigraphy, and CT, respectively). Mean per-patient specificity estimates 
were 96% for US, 93% for MRI, 85% for scintigraphy, and 95% for CT; the only significant difference in 
values was that between scintigraphy and US (P = .009). Mean per-bowel-segment sensitivity estimates 
were lower: 74% for US, 70% for MRI, 77% for scintigraphy, and 67% for CT. Mean per-bowel-segment 
specificity estimates were 93% for US, 94% for MRI, 90% for scintigraphy, and 90% for CT. CT proved to be 
significantly less sensitive and specific compared with scintigraphy (P = .006) and MRI (P = .037). There were 
no studies selected in which the accuracy of PET for the diagnosis of IBD was assessed. The authors 
concluded that no significant differences in diagnostic accuracy among US, CT, MRI and scintigraphy were 
observed. 
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Stenosis 
The definition of a stenosis may be relatively simple for an endoscopist who can record the inability or 
difficulty to advance the endoscope through a narrowing of the bowel lumen. Unfortunately, such an 
assessment is not the same for imaging and the definition of stenosis has varied in different studies. 
Stenosis is usually defined as a thickening of the bowel wall with a narrowing of the small bowel lumen, and 
some definitions include also the presence of the dilation above of the narrowing (1, 113). Others rank 
bowel stenosis as high grade (80%–100% narrowing of normal lumen), intermediate (60%–80%), low grade 
(50%–60%) and absent (0–50%)(114).  
SBFT and SBE show a low albeit significant correlation with surgical findings in identifying the number, 
localization, and extension of stenosis. These examinations may identify small bowel obstruction, but 
cannot depict the cause, indicating additional diagnostic work up often based on MRI or CT (1). In addition 
8. US, CT and MRI and SBE SBFT [EL:2b, RG:B] have a high sensitivity and specificity for the diagnosis of 
stenosis affecting the small bowel.  
Diagnostic accuracy of MRI and CT for stenosis is based on the use of luminal contrast. In partially 
obstructing stenosis, enteroclysis may provide higher sensitivity than enterography. [EL:2b, RG:C].  
Cross-sectional imaging using  CT, US, MRI [EL:2a, RG:B] and WBC scintigraphy [EL:3, RG:C] may assist in 
differentiating between predominantly inflammatory or fibrotic strictures. [EL:5, RG:D] 
7. US, CT, and MRI have a high accuracy for the assessment of penetrating complications (i.e., fistula, 
abscess) [EL:1a,RG:r A] and for monitoring disease progression. For deep-seated fistulas MRI and CT are 
preferable to US. [EL:5, RG:D]  
US and CT are widely available and facilitate early abscess drainage. [EL:5, RG:D]  
WBC scintigraphy may provide useful information when cross sectional imaging is inconclusive for 
detecting abscesses [EL:3b, RG:C]. 
9. MRI demonstrates high agreement with conventional radiology (i.e. SBE and SBFT) and CT for the 
diagnosis of superficial and transmural abnormalities. MRI is superior to conventional radiology for 
assessing the extramural manifestations, and has the advantage over CT of avoiding radiation exposure. 
[EL:2b, RG:B]  
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they have a considerably lower sensitivity for the detection of small bowel and extraluminal complications 
compared to CT or MRI (72, 107, 113, 115).  
In experienced hands, bowel US is an accurate technique for detection of small bowel stenosis, especially 
high grade stenosis that may be candidates for surgery(113). Based on the pooled data of three studies 
using surgery as reference standard , the sensitivity of US was 79% and specificity was 92%, (35).  
Use of oral contrast agents can improve the accuracy of US in detecting the presence and number of small-
bowel stenoses (sensitivity increased from 74% to 89% in one study) (116), but it is generally not necessary 
in patients with symptomatic obstruction. 
In two studies comparing CT with ileocolonoscopy, the sensitivity of CT for the detection of stenoses was 
92% and specificity 100%(72, 109). Two additional studies using endoscopy and surgery as a reference 
standard (117, 118) reported a sensitivity of 85% and 90%, respectively and both a specificity of 100%.  
Direct comparison of CT and MRI for diagnosis of stenosis in a study with 44 patients showed also a similar 
sensitivity (85% vs. 92%) and specificity (100% vs. 90%) (117). Pooled results of seven studies with adequate 
reference standard (endoscopy and/or surgery), showed that the sensitivity of MRI for diagnosis of stenosis 
was 89% and specificity 94% (35). Better distension was achieved with MR enteroclysis than with MR 
enterography resulting in a higher sensitivity (100 versus 86%, respectively) and specificity (100% versus 
93%) for detecting stenosis, though the difference was not significant (38). 
When performing CT or MRI before capsule endoscopy, between 27 and 40% of patients are excluded from 
capsule endoscopy due to the identification of a stenosis (109, 119). 
 
Differentiating between inflammatory or fibrotic stenoses 
Over and above diagnosing the presence of a stenosis,  determining the relative inflammatory and fibrous 
component of a stenosis may be helpful for guiding therapy.  
The perfusion of the intestinal wall involved in CD can effectively be studied with contrast enhanced (CE) -
US. Dynamic evaluation of the bowel wall enhancement  using CE-US can be performed with high temporal 
resolution and has been reported to correlate with the inflammatory activity in the intestinal wall in some 
studies(120), although not in others (121). 
In a study evaluating CT classification of lesion type using histopathology of surgical specimens as reference 
standard(107), it was shown that wall thickness, parietal enhancement, comb's sign and the presence 
of enlarged lymph nodes were correlated with the presence of inflammatory lesions, and it was only the 
presence of a stenosis that was associated with fibrotic changes in the intestinal wall. The study did not 
provide any means to differentiate between inflammatory and fibrous components of a stenotic lesion.  
Another study that compared CT findings with histology stated that small bowel stenoses, without CT 
findings of inflammation do not predict the presence of fibrosis. Therefore, CT criteria cannot be used to 
predict the presence of fibrous component in a stenotic lesion (122). 
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A recent study evaluated the value of MRI findings in small bowel CD in correlation with 52 surgical 
pathology specimens (115). The MRI signs significantly associated with the presence of fibrosis were wall 
thickness, T2 hyperintensity, comb sign and fistula. However, these findings were not reproduced in 
another study, in which no  correlation was found a between wall thickness and T2 hyper intensity with 
fibrosis, although in that study a layered enhancement pattern was common in fibrostenotic segments (123).  
Overall, in contrast with well-established MRI criteria for determining presence and severity of 
inflammation (123) no validated criteria have been established to reliably determine the fibrotic 
component of stenotic small bowel lesions based on MRI. 
Fistula 
At the time of diagnosis 15.5% of patients with CD have penetrating lesions (fistulas, phlegmons or 
abscesses) (124). In a systematic review, pooled results of four US studies for the diagnosis of fistulising 
lesions, using surgery (in three studies) and barium studies, surgery, or/and colonoscopy (in one study) as 
reference standard, showed a sensitivity of 74% and specificity of 95% (35). The largest study, using surgery 
as reference standard, included 128 patients with 119 internal fistulas. US showed a sensitivity of 71% and 
specificity of 96% (74). In this study, US and SBE had the same accuracy for the detection of internal fistulas 
(85%). Using the combination of US and SBE, and also considering the presence of fistulae when revealed 
by at least one method, the sensitivity in diagnosing this complication rose to 90%. The addition of oral 
contrast agents, does not improve the accuracy of US for the detection of internal fistulas (106). US may be 
used for detection of extramural complications of CD, although if CT or MRI is available, they are preferable 
for the detection of intra-abdominal fistulas (1). 
The sensitivity of CT for the diagnosis of fistulas has been reported in a systematic review. This showed 
that, based on the pooled results of five studies with surgery and endoscopy as reference standard, the 
sensitivity was 70% and specificity 97% (35). Two studies although not meeting the selection criteria of this 
systematic review , used  surgical findings as the reference standard and reported higher accuracies for 
diagnosis of fistulas. In one of these studies including 44 patients, the sensitivity, specificity, and accuracy 
of CT for the detection of small bowel fistula were 77.8%, 86.8%, and 85.1%, respectively (107). The other 
study included 36 patients, the presence or absence of a fistula was correctly determined by CT in 94% 
(125).  
The key role of cross-sectional imaging for assessment of penetrating complications of CD is demonstrated 
in a retrospective study including 56 patients, showing that in half of the patients with penetrating 
complications of CD, there was no suspicion of a fistula or abscess at pre-CT clinical assessments, with 79% 
of these patients subsequently receiving new medical therapy or undergoing surgical or percutaneous 
intervention based on the detection of penetrating CD on CT (126).  
MRI is highly accurate for the detection of abscesses, fistulae and inflammatory infiltrates in CD (127, 128).  
Pooled results of four studies with adequate reference standard (endoscopy and/or surgery) showed a 
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sensitivity of MRI for the diagnosis of fistulas of 76% and specificity of 96% (35)[97]. Other studies on MRI for 
diagnosing intra-abdominal fistulas have been published(75, 115, 129-131), but only one used surgical 
findings as the reference standard (115). Detection of small-bowel fistula by MRI had a sensitivity, specificity, 
and accuracy of 88%, 93%, and 91%, respectively, but the authors did not differentiate between abscess 
and fistula (115). MRI actually appears to be the most efficient tool to detect intra-abdominal fistulas, and CT 
and MRI are the recommended techniques for detection of extramural complications of CD(1). 
A WBC scintigraphy has no indication for the diagnosis and characterization of fistulae. 
Abscess 
Pooled results in a systematic review of three US studies for the diagnosis of abscesses using surgery as a 
reference standard reported a sensitivity of 84% and a specificity of 93%, although US accuracy has been 
reported to be highly related to disease location in CD (35). In clinical practice, if an intra-abdominal 
abscess or deep-seated fistula is suspected, US should be used only if CT or MRI is not available or in 
children in whom other methods are not feasible. 
CT and US showed an overall high and comparable accuracy in the detection of intra-abdominal abscesses, 
although CT showed a slightly greater positive predictive value than US. CT has been reported to determine 
the exact location and extent of an abscess with great reliability. Only two studies had surgery as reference 
standard for detection of extra-enteric lesions on CT (74, 107), showing that for the detection of intra-
abdominal abscesses the sensitivity, specificity, and accuracy of CT compared with surgical findings were 
85.7%, 87.5%, and 87.2%, respectively (74, 107). In a prospective study, intra-abdominal abscesses were 
found intra-operatively in 22 patients and sensitivity of CT for the diagnosis of abscesses was 85% and 
specificity 95% (74, 107). Because of its accuracy, ability to detect penetrating complications of CD, and 
high availability, CT is in clinical practice the most useful imaging modality to detect intra-abdominal 
abscesses in CD. 
Only three studies used surgery as the reference standard to assess the accuracy of MRI in detection of an 
abscess (75, 115, 130) . Sensitivity ranged from 86% to 100% and specificity from 93% to 100%. These 
studies were limited because two included fewer than five patients with intra-abdominal abscess (75, 129) 
and the third did not differentiate abscess from fistula (132). Pooling the results of these three studies 
showed a sensitivity of MRI for the detection of abscesses of 86% and a specificity of 93% (35). The access 
to MRI remains limited in some countries and image acquisition and analysis still takes longer than for CT 
(although recent developments have decreased the image aquisition time to 15-30 minutes) . These 
reasons may limit the utility of MRI as a first line examination to detect intra-abdominal abscess in CD. 
Labelled leukocyte scintigraphy can help in the localization of abscesses when the other methods have 
been inconclusive. 
 
Global bowel damage  
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 New tools, such as the Lémann score, have been proposed and are in the process of validation. This score 
measures damage resulting from inflammatory, stenosing or penetrating lesions, as well as that resulting 
from permanent loss of intestine after surgery (3) The scroe would allow measuring the cumulative bowel 
damage at a specific time in a patient’s history, measuring the progression of bowel damage over time in 
cohorts of patients and in clinical trials. It would facilitate identification of patients with CD at high (or low) 
risk of rapid damage progression, and compare the effects of treatment strategies on the progression of 
bowel damage. 
 
The prevalence of CD involving the upper gastrointestinal (GI) tract is low compared with ileal and colonic 
disease. Approximately 10%–15% of patients have associated upper GI lesions (133). Esophageal CD has 
been shown to affect the distal third of the esophagus alone in 80%, the middle and lower third in 15%, and 
the entire esophagus in 5%.  
Data on imaging in esophageal CD is sparse and sizeable series are lacking, with essentially absent  data for 
the stomach. Cross sectional imaging may reveal ulcers or strictures in oesophageal CD but superficial 
lesions are difficult to detect, underscoring the importance of endoscopy in the diagnosis of oesophageal 
CD. Endoscopy with tissue biopsy is useful to exclude other common esophageal disorders. The most 
commonly described findings on endoscopy include aphtous ulcers, superficial erosions, and late stage 
development of stricture and cobblestoning of the mucosa (134). 
One study discussed inflammatory conditions of the oesophagus (135) where diagnosis was made with 
endoscopy, barium studies, CT scan and a biopsy. Recently, the presence of an esophagobronchial fistula 
formation in a patient with CD was described in a case report (136). The authors indicated barium swallow 
as the initial test of choice to identify esophagobronchial fistulae.  
 
Mucosal healing has been associated with sustained clinical remission, and reduced rates of hospitalization 
and surgery. CD is a transmural process, so full-thickness small bowel healing or remodeling could be 
important end points. However, only few studies have explored how radiologic parameters of active 
inflammation change over time during medical therapy.  
US  
A prospective study was carried out on 15 patients with CD, using small intestine contrast ultrasound 
10. Contrast studies or cross sectional imaging can be used to detect upper GI strictures[EL:5, RG:D].  
11. Cross sectional imaging, in particular MRI, can be used for monitoring therapeutic response. 
However, there is a delayed timeline as compared to clinical or endoscopic changes [EL:3,RG:C]. 
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(SICUS) to assess changes caused by anti-inflammatory treatment and its relationship with the clinical and 
biological response (137). The parameters were measured before and after 6-month anti-inflammatory 
treatment. In 13 patients the slope of the enhancement curve and the area under the enhancement curve 
were significantly lower after anti-inflammatory treatment (P < 0.05) with a significant correlation with the 
Crohn’s disease activity index (CDAI) score (=0.85, P < 0.05). However, changes in US findings were not 
compared with another objective measure of lesion severity, namely endoscopy.  
Another prospective study was carried out on 24 consecutive patients with CD, using US to assess changes 
induced by anti-TNF therapy and its relationship with the clinical and biological response(138). The 
parameters were measured one week prior to the induction treatment and two weeks after. The anti-TNF 
therapy caused a significant reduction in the thickness of the bowel wall (P = 0.005) and Doppler flow (P = 
0.02), leading to the disappearance of US changes in 50% of the patients. However, sonographic normality 
was only achieved in five out of 17 (29%)  patients  with a clinical and biological response, and could not 
differentiate between those with and without clinical and biological response (P = 0.27). This study also 
lacked an established gold standard for assessment of mucosal healing.  Although the overall data seems 
promising, US is not ready to be used in clinical practice for assessment of therapeutic responses. 
CT 
A recent retrospective study of 63 patients with CD who underwent CT before and at variable time lengths 
after initiation of infliximab (IFX) showed that resolution of lesions can be centripetal (from the ends 
inward) and that up to 25% of patients who respond to treatment have complete normalization of what 
was abnormal small bowel(139). Poor to fair correlation was found between CT features of response and 
improved clinical symptoms (kappa 0.26), improved endoscopic appearance (kappa 0.07), and reduction of 
CRP (kappa 0.30). When comparing responders (complete and partial) with non responders, only the 
presence of “comb sign” on the index CT was predictive of radiologic response (P=0.024).  
MRI 
Various studies have shown responsiveness of MRI lesions or indexes to therapeutic interventions. A study 
in 18 patients prospectively assessed the effect of 6 month adalimumab  treatment with moderate-severe 
stricturing ileal CD (140). Before and 6 months after the beginning of adalimumab treatment, patients 
underwent ileocolonoscopy and MRE. MRE activity Index was of 7.11±1.18 and 5.1±2.22, respectively. 
Improvement in inflammatory parameters was observed both in relation to the MRE activity index (p= 
0.003) and the SES-CD score (p = 0.0005), compared with 6 months before.  Authors conclude that MRE 
activity index could be helpful for assessment of healing of inflammatory lesions. 
 
PET-CT 
CD strictures usually represent a continuum of active inflammation, muscular hypertrophy, and fibrosis: all 
are present, in varying degrees, in any particular stricture (107). Most strictures (defined as luminal 
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narrowing with prestenotic dilation) will have some imaging findings of inflammation, but these imaging 
findings do not correlate with reversibility of the stricture. Combined PET-CT enterography may overcome 
this weakness because poor uptake of the PET tracer FDG may predict failure of medical therapy (142). 
Although a study of inflammatory and fibrotic strictures demonstrated a range of FDG uptake, patients with 
predominant fibrosis had lower FDG uptake (143). 
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WG3: Colon and rectum, CD and UC excluding cancer. 
Most studies employing US, MRI and/or CT for assessment of IBD activity included CD patients with small 
bowel rather than colonic disease. Moreover, not all studies describe disease location, activity and severity. 
Different designs, samples (often small) and technical aspects confound observed differences between 
techniques. In the present section, only studies comparing imaging findings to a reliable reference standard 
(endoscopy and/or surgery) in patients with both suspected and established IBD are considered.  
 
 
 
Diagnosis of colonic inflammation 
Sensitivity of abdominal US for diagnosis of CD and UC was 71% to 86% and 62% to 89%, respectively, and 
increased to 96% and 91%, respectively with hydrocolonic sonography (144, 145) . It has been suggested 
that CD can have differential US characteristics  compared to UC using hydrocolonic sonography that 
include: mucosal thickness greater than 1.5 mm, bowel wall thickness greater than 4 mm, mucosal 
irregularity, or absence of haustra (146) . However, other studies provided conflicting evidence with similar 
changes in colonic CD and UC, findings mainly influenced by the severity of the disease (146, 147). 
Sensitivity and specificity of CT for diagnosis of colonic IBD has not been specifically assessed; all studies 
assessing accuracy of CT include also small bowel. In a meta-analysis of 33 studies, Horsthuis et al. 
concluded there was no significant difference in diagnostic accuracy between US, MRI and CT for diagnosis 
of IBD in large and small bowel when compared to an independent reference standard. UCs can be 
distinguished from CD by disease location, extent, and morphology of colonic wall thickening (148). 
The accuracy of MRI with luminal distention, e.g. colonography, for assessment of colonic IBD was 
described in various prospective studies. Schreyer et al. found sensitivity for inflammation on a per-
segment analysis 31.6% for CD and 58.8% for UC. In CD, most cases of mild inflammation were not 
visualised by MRI and even severe inflammation in UC was not always depicted by MRI (149). Ajaj et al. 
reported sensitivities and specificities of 87% and 100% for diagnosing IBD (150). When using diffusion-
weighted imaging without oral or rectal preparation, sensitivity and specificity for detecting colonic 
inflammation was 89.5% and 86.67% respectively for CD, and 58.3% and 84.5% for CD (151). In two 
13. The performance of imaging depends on the type of colitis and severity (EL:1b, RG:A). 
Transabdominal US and MRI have a high accuracy for assessing the activity and severity of Crohn’ s 
colitis [EL:1b, RG:A]; the performance in UC is less clear. The role of CT for distinguishing quiescent from 
active colonic IBD is currently not defined. 
White blood cell scintigraphy can detect colon inflammation and can be used as an additional technique 
(EL:2b, RG:B). 
12.MRI, CT and US imaging are an adjunct to endoscopy for diagnosis of colonic IBD. MRI and CT have 
higher sensitivity for examining locations difficult to access by US. [EL:2a, RG:B]. 
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prospective studies(152, 153) by Rimola et al. showed sensitivities and specificities higher than 80% for 
diagnosis of active disease. 
  
Disease extent 
US can accurately localize colonic disease proximal to the rectum, whereas rectal disease can easily be 
missed by this technique (154).  CT sensitivity was low (38%) in the ascending colon in the single 
prospective study that used a reliable reference standard; this may be due to lack of endoluminal contrast 
(155). Three studies assessed the accuracy of MRI for diagnosing the extent of colonic CD and UC, with 
sensitivities and specificities ranging from 38 to 88% and 88 to 90% respectively (155) (156) (157). 
 
US in CD. The role of US to assess activity has been most extensively investigated for small bowel CD. When 
considering colonic CD, US is most accurate in the sigmoid/descending colon, followed by the 
caecum/ascending, and transverse colon, while accuracy for rectal disease is poor (154) (104) (158). 
 A systematic review of 6 studies investigating US for assessment of ileo-colonic CD found sensitivities 
ranging from 63% to 100% and specificities from 77% to 100% (7) (159) (160) (161) . A study using a 
heterogeneous case mix (48 CD, 23 UC, 3 unclasified colitis, 44 controls) (159) , reported high sensitivity, 
specificity and accuracy for high resolution (HR) sonography  when assessing CD activity (per-patient basis: 
94%,  67% and 93%; per-segment basis: 80%, 67% and 80%, respectively). It has been suggested that 
contrast-enhanced Doppler US may assess CD inflammatory activity within colonic strictures impassable by 
endoscopy (162) (163) (164). A comparable accuracy was shown by CEUS and Doppler US, although 
correlation with CDAI was strongest for CEUS than for US (7). Several studies found significant correlations 
in CD severity between US (using wall thickness) and colonoscopy (156) (7) (8, 35, 130, 165, 166) (113) (167, 168), barium 
contrast (130)[174] CT/MRI, surgery or histology (154) (7).   
Some studies reported  good correlations between various clinical and endoscopic activity indexes and 
severity of colonic lesions as assessed by hydrocolonoc sonography68], but these findings have not always 
been reproduced; other studies found weak or no correlation between CD severity as assessed by US and 
several clinical and haematochemical parameters of inflammation(113, 130, 146, 154, 156, 158, 167).  
 
US in UC. Because UC involves the mucosa continuously from the rectum,  colonoscopy with biopsy is the 
reference standard for assessment of disease extent, activity, and severity. Nevertheless, in experienced 
hands, US is an alternative, particularly in patients not requiring biopsy and/or with severe comorbidities. 
In 4 studies assessing the diagnostic accuracy of US (74 patients), sensitivities ranged from  48% to 100% 
and specificities from 82% to 90%(169). Current evidence indicates that diagnostic accuracy of US is related 
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to disease site, as sensitivity is high for sigmoid/descending colonic disease (reaching 97 %)(154), but low 
for rectal disease(170). The utility of US for assessing activity has been assessed in a study including 38 IBD 
patients (12 UC) and 6 controls(158),  the mean colonic wall thickness was 3.2 mm in both CD and UC, 
being higher in moderately (n=46; p<0.001) or severely inflamed bowel (n=20; p<0.001) compared to 
normal segments (n=58). However, these studies frequently depend on specifically experienced 
sonographers and may not be generalizable. 
 CT in CD. The diagnostic utility of CT in CD colitis was investigated in 3 studies including 85 patients (155, 
157, 171, 172). Sensitivity and specificity for activity ranged from 60% to 90% and from 90% to 100%, 
respectively. Lowest sensitivity was achieved when luminal contrast was omitted(155). One study 
compared CT-colonography and high-resolution video-endoscopy (171); the colonic wall tickness on CT 
correlated with the presence of ulceration (r =0.69, p < 0.01), active CD  (r=0.81,p=0.001), pseudopolyps 
(r=0.72,p=0.01) and fistulae (r=0.77,p=0.002) at endoscopy. Increased vascularity correlated with mucosal 
inflammation (r=0.72,p< 0.01) while no correlation was found between CDAI and any CT finding(171). A role 
for CT colonography (virtual colonoscopy) has been proposed to assess postoperative recurrence, although 
the observed false negative rate supports continued use of colonoscopy(173), unless strictures are 
impassable.   
CT in UC.  Few studies have investigated CT to assess UC, finding an overall sensitivity of 74% when using CT 
enterography to detect colonic inflammation(174, 175). Although preliminary studies in small samples(176, 
177) report good correlation between disease extent by colonoscopy and PET/CT (κ 55%; p=0.02), further 
studies are needed. A study of CT in 21 patients(171), found loss of haustration, a rigid bowel wall, and 
bowel thickness were moderately correlated with UC severity (r = 0.612). Overall, the limited  available data 
using CT or CT colonography in UC does not demonstrate adequate diagnostic performance (178, 179) and 
colonoscopy remains the reference standard. Indications for CT are currently restricted to patients with 
impassable stenoses or severe comorbidities where colonoscopy is contraindicated(179).   
MRI in CD. MRI may provide useful information in colonic CD, including wall thickening, presence of ulcers, 
depth of mural penetration, edema, loss of haustration, polyps, extraluminal findings/complications, 
although early disease may not be detected(153). 13 studies investigated colitis activity using an 
appropriate reference standard(131, 149, 151-153, 155, 157, 160, 172, 180-184). Per-patient analysis(131, 
155, 160, 181-183) found high sensitivity and specificity, ranging from 78% to 100% and from 46% to 100%, 
respectively. On a per-segment analysis(149, 151-153, 157, 169, 172, 180, 184), sensitivity and specificity 
ranged  from 55 to 87% and 84% to 98% respectively(169). The sensitivity and specificity of MRI was 
investigated in 8 studies using  colonoscopy as reference standard(149, 151-153, 169, 182-184). Overall, 
good correlation was found between endoscopic severity and MRI findings, which was higher with luminal 
distension (151, 169, 184). Significant correlation was observed between MRI and endoscopic activity 
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indices in 5/6 studies (ranging from r=0.34 to r=0.85)(151, 152, 156, 182-184).  In 3 of these, a MRI activity 
index significantly correlated with the endoscopic activity index, including both qualitative (151) and 
quantitative indices (152, 153). In 4 studies describing a segmental analysis (151-153, 182), 768 segments 
were analyzed, of which 230 were active (29%).  High correlation between endoscopic activity and MRI 
(p<0.001) was reported (151, 152, 182). All studies found no or very weak correlation between MRI findings 
and both clinical and indices of inflammation or alterations in biomarkers (114, 129, 131, 153, 156, 180, 
182, 183). However, a total MRI score (MR-score-T) did correlate with both a simplified endoscopic activity 
score (r=0.539,p<0.001) and with the CDAI (r=0.367;p<0.004)(151). Overall, MRI may be useful to assess CD 
colitis after incomplete colonoscopy, in patients not requiring biopsy, or those with severe co-morbidities, 
and where extraluminal complications are suspected(114, 129, 131, 149, 151-153, 180-184). 
MRI in UC.  Findings of initial studies suggesting that MRI may be valuable for assessment of UC (185, 186), 
were later substantiated in larger studies (187-190).  Indeed, various studies reported higher sensitivity for 
MRI in UC (58.8%-68%) than CD (31.6%-40%)(149) (191),. In a larger study (151), the accuracy of diffusion-
weighted (DWI) MRI for colitis was also greater in UC (n=35) than CD (n=61) (p<0.003). A segmental MRI 
score (MR-score-S) >1 had a sensitivity and specificity of 89% and 86% when compared with endoscopic 
assessment of inflammation (AUC 0.920, p<0.0001). For CD, a MR-score-S >2 detected inflammation with a 
sensitivity and specificity of 58% and 84% (AUC=0.779, p<0.0001). MRI performs better in moderate-to-
severe UC (192) than in mild disease.  
Other techniques. Scintigraphy with radiolabelled leucocytes is a valid option to cross-sectional imaging to 
demonstrate disease activity in CD. A normal scan makes very unlikely the presence of active disease with 
high accuracy (50, 55, 193). 
 
 
 
 
This section is devoted to complications mostly related to colonic CD, including fistula, abscesses and 
stenosis. Only studies reporting results for colonic lesions and with an adequate reference standard (i.e. 
endoscopy and/or surgery) are considered. 
Detection of intraabdominal fistulas and abscesses 
Three studies investigating US for diagnosis of fistuliszing complications (74, 130, 182, 194) found 
15. Contrast enema or cross sectional imaging can be used to diagnose and assess colonic strictures and 
accuracy is improved with colonic distension.[EL:2b, RG:B]  
14. Accuracy of Ultrasound, CT, and MRI is less well defined for the assessment of penetrating colonic 
IBD [EL:2b, RG:C].  
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sensitivities ranging from 71% to 87%, with specificities ranging from 90% to 100%. Only one study 
investigating CT for diagnosis of fistulas used an adequate reference standard, finding sensitivity and 
specificity of  68% and 91% respectively (74). The diagnostic utility of MRI for intraabdominal colonic 
fistulas was determined in three studies (129-131), reporting sensitivities between 71% to 100%, and 
specificities from 92% to 100%. In the only study reporting results separately for colonic and small bowel 
segments, similar sensitivity, specificity and overall accuracy was found for all segments (129).  
Various studies have compared the performance of different cross-sectional imaging modalities. The 
diagnostic accuracy of CT and US for diagnosis of intra-abdominal fistulas complicating CD was similar in a 
study using a surgical reference standard: sensitivity and specificity were 68% and 91% for CT compared 
with 87% and 91% respectively for US (74). In another study using a combination of endoscopy, barium 
studies, CT, and surgery as reference standard, 17 cases with enteroenteric fistulas were identified(130). US 
and MRI detected 14 (82%) and 12 (70%) fistulas respectively. Specificity and accuracy were 100% and 90% 
for US versus 92% and 80% for MRI.  
The value of US for the detection of abscesses was assessed in three studies using a surgical reference 
standard(74, 129, 194), finding sensitivities ranging from 81% to 100%, with specificities of 92% to 94%. 
One study found that intra-abdominal abscesses were correctly detected in 9/9 patients and excluded in 
22/24 patients (sensitivity 100%, specificity 92%)(194). The higher accuracy reported in this study may be 
due, at least partly, to patient selection by excluding cases with lesions in anatomic areas that are difficult 
to assess by US, in particular the stomach, the deep pelvis, and the rectum.  
The value of CT to detect intra-abdominal abscesses in patients with CD colitis was investigated by two 
studies from the same group (195, 196) showing sensitivities of 86 to 100% and specificities of 95 to 100%. 
Two similar studies using MRI (197, 198) found sensitivities of 75% and 86%, and specificities of 91% and 
93%.  
A comparison of US and CT (74)  found that abscesses were correctly detected in similar proportions (US 
91%, CT 86%), although overall accuracy was higher for CT (92%) than for US (87%) because of US false-
positives. Both methods missed only deep abscesses: five by US in the entire series (three interloop, one 
mesenteric, and one appendicular) and three by CT (two interloop and one mesenteric). The combination 
of CT and US did not significantly improve the diagnostic accuracy overall.  
Detection of stenosis 
Two studies found that US had high diagnostic accuracy for detection of small bowel and colonic stenosis, 
(199, 200) with sensitivities of 75% and 100%, and specificities of 93% and 90%. In the single study 
reporting small bowel and colonic findings separately, US sensitivity was not significantly affected by the 
site of stenosis(200).  
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None of the four studies investigating the utility of CT for assessment of stenosis, and using an appropriate 
reference standard, provided data regarding colonic stenoses (72, 109, 118, 155).Based on the high 
accuracy of CT for detecting small bowel stenosis (sensitivity 85% to 93%, specificity 100%) it is plausible 
that CT may be useful for similar colonic lesions.  
Four studies investigated the utility of MRI for the detection of colonic stenosis in CD (197, 198, 201-203), 
with sensitivities ranging from 75% to 100%, and specificities from 91% to 100%.   
At the time of writing, there is no direct comparison of cross sectional imaging techniques for diagnosis of 
colonic strictures. 
Limitations of selected studies  
Studies using a surgical reference standard will have a spectrum bias towards more severe intestinal 
complications in CD, and likely overestimate diagnostic sensitivity, due to the presence of more severe 
lesions, and diagnostic specificity due to a higher prevalence of lesions in the operated population. 
Comparisons of diagnostic accuracy are also limited by different diagnostic thresholds and criteria across 
studies; standard definitions for individual complications from a radiologic perspective for each of the 
available techniques are elusive. Such definitions would facilitate comparisons across studies and overall 
conclusions. Some recent progress has been made in this regard for US and CT; standard definitions are 
currently more obscure for MRI. 
 
 
 
Value for therapeutic monitoring 
Mucosal healing has emerged as an important treatment goal for patients with inflammatory bowel disase. 
Various studies have assessed the value of cross sectional imaging techniques for therapeutic monitoring in 
CD, using US (106, 170, 204), CT(205), or MRI (206), although the terminal ileum was also assessed in these 
studies, and results are not reported separately for colonic disease 
The utility of US for assessing activity and drug response has been compared with colonoscopy (106, 170, 
204), with high concordance (weighted κ between 0.76-0.90). US may also provide prognostic information; 
moderate/severe US scores at 3 months were associated with increased endoscopic activity at 15 months 
(OR 5.2; 95% CI 1.6-17.6 and OR 9.1; 95% CI 2.5-33.5, respectively)(170). 
The value of CT was assessed in a retrospective North American study including 63 patients with CD 
receiving infliximab(205). Of 105 lesions, 21 (20%) were colonic. Poor to fair correlation was found between 
CTE features of response and improved clinical symptoms (kappa 0.26), improved endoscopic appearance 
16. MRI is accurate for therapeutic monitoring in colonic Crohn’s disease. [EL:2b, RG:C]. The accuracy of 
other modalities is less well defined. 
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(kappa 0.07), and reduction of CRP (kappa 0.30). When comparing responders (complete and partial) with 
nonresponders, only the presence of “comb sign” on the index CTE was predictive of radiologic response 
(P=0.024)(205). 
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WG4: Perineum including anus, genital tract. 
 
17. MRI is the most accurate diagnostic imaging test for perianal CD with accuracy surpassing 
Examination Under Anaesthesia (EUA), and is recommended during the initial diagnosis unless there is a 
need for immediate drainage of sepsis. EL: 1b RG:B 
Endosonography (with or without hydrogen peroxide) is superior to clinical examination and is an 
alternative to MRI. EL: 1b RG:B 
 
The diagnosis and classification of perianal disease is often reached using a combination of both clinical and 
imaging findings. Examination under anaesthesia (EUA) in the hands of an experienced surgeon has been 
considered the gold standard in the assessment of perianal CD as it provides opportunity for both full 
staging and treatment such as drainage of sepsis and placement of non-cutting setons. Many comparative 
studies have been performed evaluating US and MRI in the diagnosis of perianal CD fistulae (207-217), 
pouchitis and urogenital complications. Both US (with and without hydrogen peroxide) and MRI are able to 
identify and classify fistulous tracts with good accuracy. The diagnostic accuracy of MRI ranges from 80 to 
100% in most reported studies. The diagnostic accuracy of endoanal US (EUS) is variable and in general 
ranges from 50 to 100%. In general endoanal probes are utilised, although studies using alternative 
approaches such as transperineal have reported high sensitivity (218). 
 Schwartz et al (45), in a prospective blinded study comparing EUA, MRI and EUS demonstrated a diagnostic 
accuracy of 91%, 87% and 91 % respectively with 100% accuracy when any 2 of the tests were combined.  A 
larger prospective clinical trial comparing preoperative digital rectal examination, US and body-coil MRI 
showed MRI to be superior to US for abscess detection, which in turn was superior to clinical examination 
(85%, 75% and 33% sensitivity respectively). Good data exists demonstrating MRI may correctly change 
surgical management in patients with perianal CD (207, 219). Given its non invasive nature, MRI should 
precede simple diagnostic EUA unless there is a need for immediate drainage of sepsis.  Although 
endoscopic US has been found to have high diagnostic accuracy (45), its use may be limited by luminal 
stenoses and transvaginal and transperineal US techniques may be more useful in this instance (220). 
 
18. In urogenital CD, clinical examination, EUA, MRI, CT and ultrasound may all be used.  
Contrast studies have a diminishing role.  
EL: 4 RG:D 
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Many imaging modalities including MRI, fluoroscopy, CT and US may be employed for diagnosis of 
urogenital complications such as entero-vaginal and entero-vesical fistulae. There remains a lack of 
controlled data in this field with little evidence to recommend one technique over another.  Small series 
report successful use of MRI in detecting pouch related complications such as fistula and leaks (221).  
US and MRI are superior to clinical examination in classifying fistulae (9) and their findings should inform 
final classification. Clinical examination should be supplemented with imaging and/or EUA for full and 
accurate fistula classification. 
The perianal disease activity index (PDAI) (222) is a clinical scoring systems which has been used and 
validated in clinical studies both at diagnosis and to measure treatment response. CDAI measures intestinal 
and extraintestinal manifestations of CD and as such is not accurate in assessment of perianal disease 
specifically (223). The fistula drainage assessment (FDA) has been used in several clinical trials of medical 
therapy (224-227), but is very much investigator dependent and has not been validated in large studies. A 
single retrospective study has evaluated the PCDAI scoring system, where high scores predicted short term 
surgical outcome, but this has not since been validated (228). MRI classifications of fistula severity have 
been proposed such as the system published by Van Assche et al (229), but have limited use so far outside 
formal clinical trials.  
There is no single widely accepted and validated severity clinical scoring system for perianal fistula in CD. 
Both the perianal disease activity index (PDAI) and Fistula Drainage Assessment (FDA) may be used to 
measure fistula activity in clinical trials.     
19. Undetected or untreated fistulae extensions and abscesses are the major cause of treatment failure. 
Imaging, particularly using MRI, is highly accurate in detecting such complications and for treatment 
planning. 
EL: 1b RB:B 
 
Full and accurate staging of perianal fistulae complicating CD is essential for therapeutic planning and 
ultimately achieving optimal clinical outcomes. Data suggest that the finding of rectal inflammation and or 
stenosis has prognostic implications and are relevant in determining the treatment approach. Rectal 
inflammation often indicates the presence of complex fistulae and associated complications such as 
abscesses (1).  Often endoscopic examination of the rectum and colon is needed to determine the presence 
of macroscopic inflammation and/or anal stenosis and is useful for planning treatment of perianal CD.  
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Undiagnosed extensions and abscesses are the major course of recurrent disease after attempted surgical 
cure (208). Furthermore, full knowledge of the presence of these complicating abscesses and extensions is 
required before appropriate deployment of medical therapy, particularly with anti-TNF (230). 
Good evidence is available to inform use of investigations for staging and detection of complications prior 
to therapy. Notably two prospective and blinded studies have evaluated the effect of preoperative MRI on 
clinical outcome after surgical treatment for perianal fistula disease (207, 208). Both studies showed that 
MRI revealed additional and clinically relevant information to the surgeon performing EUA. Recurrence 
rates after fistula surgery are improved if the findings of preoperative MRI are used to inform the surgical 
approach. US also has high reported accuracy for detecting complications of perianal CD (45, 231-233) and 
may also be useful in treatment planning, particularly in non-recurrent disease. Use of US may be restricted 
due to patient discomfort, and the field of view is less than external coil MRI.  Comparative prospective 
data using a robust outcome based reference standard suggests MRI is superior to US for detecting 
complicating abscesses (234) and in general use is preferred in CD, especially in recurrent or suspected 
complex disease. 
 
20. MRI and endosonography are both superior to simple clinical assessment at assessing treatment 
response, particularly for detecting residual abscesses, and either should be considered prior to 
significant changes in, or cessation of, surgical or medical therapy.  
EL:2b RG:B 
 
The definition for fistula healing in the literature is varied, and there is no consensus on when a first or 
definitive evaluation of fistula healing should be performed (223). The PDAI (222) has been validated in 
patients undergoing treatment with antibiotics and azathioprine and has been used as a secondary end 
point for infliximab trial for the closure of perianal fistulae (222). Subsequent trials on biologics and 
immunomodulators have used physical examination using gentle finger compression to assess whether 
drainage occurred to define a primary end point of >50% reduction in the number of draining fistulae on 
two or more consecutive study visits (226, 230, 235). There are no studies to compare the reproducibility of 
this method to that of the PDAI. 
MRI is increasingly used to assess fistula healing, particularly during medical therapies (229, 236, 237). 
Various MRI classifications have been proposed, including the Van Assche score (229) which considers  the 
number of fistulae, localization, extensions, T2 hyperintensity, abscesses and rectal involvement. Changes 
in contrast enhancement have also been proposed as a means to monitor fistula activity (217).  
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There is no consensus on when the first or definitive evaluation of fistula healing should be performed. It 
has been shown that fistulae may reopen after cessation of therapy and studies using MRI findings as a 
more stringent endpoint of deep fistula healing suggest MRI (229, 230, 237) and endoanal US (232, 238) 
may be useful for identification of fistulae that show external closure but retain an internal fistula tract. 
This suggests imaging assessment of deep healing is superior to simple clinical evaluation, although long-
term comparative studies are lacking. Direct comparisons between MRI and endoanal ultrasound are also 
lacking although use of MRI is more clinically widespread.    
 
21. The role of imaging in anorectal stricturing or carcinomatous transformation is limited to staging of 
confirmed disease and assessing the severity of known stricture. 
Confirmation of CD related anorectal malignancy should be made using established clinical, endoscopic 
and histopathological criteriaEL: 4 RG: D 
 
Long term complications of perianal CD include the development luminal stenosis and anal carcinoma. The 
limited available evidence suggests imaging is insensitive for diagnosis of carcinoma (239-241), and use is 
limited to staging of confirmed disease. Confirmation of carcinomatous transformation in the context of 
chronic CD related fistulation should be made using established clinical and histopathological criteria.  Both 
MRI and US have been used in the context of staging anal cancer although the larger anatomical coverage 
afforded by MRI suggests it should be used as first line (242).  Clinical evaluation and conventional 
endoscopic techniques remain first line for detection luminal stenosis.  
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WG5: Liver and biliary tract. 
 
22. Ultrasound is the first-line non-invasive imaging procedure in the work up of elevated liver  enzymes 
and to differentiate intra- from extra-hepatic cholestasis. [EL:2, RG:B]  
Magnetic resonance cholangiopancreatography (MRCP) should be considered in patients with 
unexplained cholestasis if ultrasound and laboratory results are non-diagnostic. [EL:1, RG:A] 
Endoscopic ultrasound (EUS) is an alternative to MRCP for evaluation of distal biliary tract obstruction. 
[EL:2, RG:B]  
 
Elevated liver or cholestatic enzymes in IBD should be further investigated (243). If drug induced liver 
toxicity is unlikely, primary sclerosing cholangitis (PSC) should be considered. Other hepatobiliary diseases 
more frequently observed in IBD than in normal controls including NAFLD/NASH, gallstone disease, 
reactivation of hepatitis B, primary biliary cirrhosis and liver cirrhosis should also be considered. 
US is usually the initial diagnostic step to exclude intra- and extrahepatic cholestasis or lesions within the 
liver as US is sensitive and specific, relative inexpensive and non-invasive (244-246). CT is associated with 
radiation exposure, is highly specific and has moderate sensitivity for the detection of bile duct narrowing 
and choledocholithiasis (247). ERCP has been considered to be the gold standard for imaging of the biliary 
tract. However, because of potential complications it should be restricted to selected cases. MRCP has 
been shown to be a safe alternative to ERCP in many cases and has similar sensitivity and specificity in 
detecting bile duct abnormalities (248, 249). 
EUS is equivalent to MRCP in detecting common bile duct abnormalities (250-252). In endoscopic units with 
good experience with this method, EUS may therefore be used instead of MRCP for detection of bile duct 
stones and other lesions that cause extrahepatic obstruction. Therefore, when the requirement of 
intervention is unclear, MRCP or EUS should be performed first, in order to avoid ERCP (253, 254). 
 
 
23. Diagnostic endoscopic retrograde ERCP should be reserved for highly selected cases in patients with 
normal high quality MRCP, but high suspicion for PSC, when cytology is required or in patients with 
contraindications for MRI due to high complication rate. [EL1, RGA]  
ERCP should also be reserved for patients where a therapeutic procedure is anticipated such as stenting 
or balloon dilatation. [EL:2, RG:B]  
 
For many years ERCP has been considered to be the gold standard to detect PSC. In recent years many 
studies have confirmed that MRCP has similar diagnostic value as ERCP in detecting PSC (249, 255-257). 
Sensitivity for detection of small duct PSC may be slightly higher in ERCP even though MRCP is almost as 
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accurate as ERCP (249, 256). Recent meta-analysis shows that MRCP has excellent accuracy (area under the 
curve of 0.91) in the diagnosis of PSC which supports that initial MRCP with negative results followed by 
MRCP would be a cost-effective approach to diagnosing PSC (249). MRCP should therefore be first line 
procedure and ERCP should be restricted for highly selected cases. Differentiating benign strictures in PSC 
from cholangiocarcinoma is still a diagnostic challenge (254). In a prospective study for evaluation of bile 
duct strictures comparing ERCP, MRCP, CT and EUS, sensitivity and specificity relating to bile duct strictures 
for diagnosis of malignancies are 85%/75% for ERCP, 85%/71% for MRCP, 77%/63% for CT and 79%/62% for 
EUS (258). However, ERCP may be associated with significant complications such as bleeding after 
sphincterotomy in 2%, pancreatitis in 3-5%, cholangitis in 1% and procedure related mortality in about 0.4% 
(259-261). ERCP should therefore be restricted to cases with extrahepatic obstruction with need for 
endoscopic intervention, when intraductal ultrasound, histology or cytology is required (262-267). Other 
reasons to perform ERCP may be contraindications for MRI. Patients with established PSC should undergo 
regular screening in order to detect abnormalities of the biliary tract suspicious for hepatobiliary 
malignancies in particular cholangiocarcinoma. First line diagnostic procedures to follow up patients with 
PSC are ultrasound and MRCP (268). Bile duct strictures and progressive marked dilatations in patients with 
PSC are suspicious for cholangiocarcinoma and should be further investigated with ERC for cytology, 
histology and eventually IDUS (265, 266). 
  
 
 
 
 
 
In patients with otherwise unexplained intrahepatic cholestasis, normal high quality MRCP or ERCP and a 
negative AMA test a liver biopsy should be considered for diagnosis of small duct PSC and other liver 
diseases. Patients with small duct PSC have biochemical and histological features compatible with PSC 
while having a normal cholangiogram (268, 269). In a large multicenter trial small duct PSC was associated 
with IBD in about 80% (270). 78% of these patients had UC, 21% had CD. Small duct PSC appears to be a 
distinct form of hepatobiliary disorders in IBD patients which can only by diagnosed by histopathological 
features and with better prognosis than PSC (271-273).  
  
24. Ultrasound guided liver biopsy should be considered for diagnosis of small duct PSC and other 
liver diseases in patients with otherwise unexplained intrahepatic cholestasis, normal high quality 
MRCP or ERCP and inconclusive laboratory work up,.[EL:3, RG:B] 
 European evidence-based consensus on the use of imaging techniques in IBD diagnosis & management  (1.9.1)   32 
WG6: Special situations: Emergency situation (acutely ill patients to be 
investigated) 
 
25.Diagnosis and management of gastrointestinal haemorrhage remains a domain of endoscopy. If the 
bleeding cannot be located by endoscopy CT or catheter angiography should be performed, unless the 
patient requires immediate surgery. EL 1A; GR A 
 
Gastrointestinal bleeding is a common cause for hospital admission that results in significant morbidity for 
patients affected by IBD. Identifying the source of bleeding can be difficult since many patients bleed 
intermittently or stop bleeding spontaneously. With the continued advances in endoscopic technology, 
colonoscopy and gastroduodenoscopy have become not only diagnostic but also a useful therapeutic tools 
in the management of acute gastro intestinal bleeding (GIB) in stable patients. Despite the lack of IBD 
specific studies, colonoscopy performed within the first 24 hours of admission may result in a definitive 
diagnosis in up to 96% of patients. (274, 275) 
After standard endoscopy, in the setting of obscure gastrointestinal bleeding double balloon enteroscopy 
(DBE) might be the initial test to perform (276). According to a recent metanalysis (276) DBE seems to have 
similar diagnostic performances as capsule endoscopy (CE), with the main advantage to be also an 
interventional procedure.(277).  
CE is superior to push enteroscopy for diagnosing clinically significant small bowel pathology in patients 
with OGIB; a recent metanalysis reported the yield for CE and push enteroscopy of 63% and 28% 
respectively.(278) 
About radiological procedure, diagnosis and management of acute gastrointestinal hemorrhage in IBD 
patients has been mainly investigated in retrospective studies and case series.  
The most recent study included 123 patients with gastrointestinal hemorrhage of obscure origin that was 
investigated with capsule endoscopy (CE) in combination with multidetector CT. The study showed 
integrating the procedures improved the diagnosis, but that for lesions such as CD, CE was superior to 
MDCT in diagnostic value due to its ability to directly display small intestinal mucosa (279). 
Despite the lack of IBD specific studies the value of MDCT in acute gastrointestinal bleeding, a recent 
prospective study evaluated the accuracy of this technique for detection and localization of acute massive 
gastrointestinal bleeding, using angiography as reference standard, showed that overall patient-based 
accuracy for detection of acute GI bleeding was 88.5% (280). 
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26. In acute, severe colitis a plain abdominal radiograph is an acceptable first study to detect toxic 
megacolon  defined by amid transverse colonic dilation >5.5cm., In equivocal or selected cases CT could 
be a used as the primary imaging modality to screen for complications (e.g. perforation, abscess, 
thrombosis, ischemia) that require emergent surgery. Toxic megacolon is also predicted by the extent of 
small bowel and gastric distension in most patients with severe colitis. EL: 3a; RG:B 
 
Toxic megacolon represents a serious complication of mainly inflammatory or infectious conditions of the 
colon, commonly associated with IBD, i.e., UC or ileocolonic CD (281). 
Diagnosis is made by clinical evaluation for systemic toxicity and imaging studies. Detection of colonic 
dilatation greater than 5.5 cm by means of plain abdominal x-ray is still the most established radiological 
criterion of toxic megacolon. However, other radiological signs, such as increased small bowel gas, 
persistent small bowel distension and distension of the stomach, mucosal islands, colonic dilatation and 
colonic deep ulceration, may predict the failure of medical therapy in patients with severe colitis, together 
with a higher risk of developing toxic megacolon and the need for colectomy (282-286). 
Small case series showed that in patients with toxic megacolon, CT scan and transabdominal intestinal 
ultrasound may be promising alternatives providing additional information (287, 288). In particular, CT scan 
is potentially an important tool in the diagnosis of abdominal complications including toxic megacolon, 
perforation or ascending pyelophlebitis. Imbriaco and Balthazar showed that in 4 out of 12 patients, CT 
scan found abdominal complications missed clinically and on plain abdominal films (287). However, larger 
clinical studies are warranted to assess the diagnostic benefit  of radiological studies in the assessment of 
toxic megacolon. 
 
27. Abdominal ultrasound and and plain X-ray should be considered in all patients with acute abdominal 
pain and established IBD. CT should be considered in patients with suspected perforation and negative or 
inconclusive first line studies,  EL:2b, RG:B   
Spontaneous free perforation is a rare but often serious event in the clinical course of CD, and may a result 
of a superimposed malignant process, i.e., adenocarcinoma or lymphoma. It is estimated that 
approximately 1-15% of patients with CD will present with a free perforation initially or eventually in their 
disease course (289, 290). 
The early diagnosis of this condition is an important determinant of survival. A study by Hattori et al. 
including 10 CD patients with free perforations showed that CT scan was significantly more sensitive than 
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plain radiography for detecting free air in the abdomen at the time of perforation (291). However, a 
retrospective review of CT scans enrolling 76 patients with various diseases (including 5 CD patients) with 
proven alimentary tract perforation showed that CT scan yielded 65 true-positive and 11 false-negative 
cases, including 1 CD patient with mesenteric phlegmon and obstruction and concluded that CT is a 
valuable method for intestinal perforation but with a sensitivity of 85.5%(292). 
It should be taken into account that frequently in CD patients, intestinal perforation presents as a peri-
intestinal abscess that may be detected by cross sectional imaging methods such as US, MRI or CT. A recent 
systematic review showed that in this context the three techniques have a high accuracy for identification 
of fistulas, abscesses and stenosis (sensitivities and specificities >0.80), although US has false positive 
results for abscesses (293). 
 
28. Acute postoperative complications in IBD patients (e.g. anastomotic leaks, abscesses, intestinal 
intussusception, mesenteric vein thrombosis, obstruction) should be initially investigated by CT or 
ultrasound followed by immediate CT if negative or equivocal. Fluoroscopic studies are also effective for 
assessing anastomotic leaks, in particular distal anastomotic leaks.  EL:4, RG:C 
 
Anastomotic leaks after intestinal surgery. may be easily diagnosed on clinical grounds due to their 
characteristic presentation in the post operative period.. However, sometimes this complication has no 
definitive signs and symptoms, and correct and prompt diagnosis by the radiologist is necessary for 
successful management. 
Although few studies have been designed to assess the detection of these complications in CD patients, 
most of the available data is derived from the surgical literature. 
A prospective database of two colorectal surgeons carried out over a 10-year period, showed that 
anastomotic leaks are frequently diagnosed late in the postoperative period and often after initial hospital 
discharge. In this study CT scan was the preferred diagnostic modality when imaging is required (294). 
On the other hand, other studies showed that most postoperative CT features overlap between patients 
with and without clinically important anastomotic leaks and that CT studies performed on patients shortly 
after abdominal surgery are not definitive. A negative CT study does not rule out postoperative lower 
gastrointestinal tract leak(295, 296). 
Ileal-pouch-anal anastomosis (IPAA) surgery preserves fecal continence for improved quality of life in 
patients who require proctocolectomy for treatment of intractable IBD. The main acute complication of 
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IPAA include anastomotic leak and abscesses. Leaks from the blind end of the pouch and the pouch-anal 
anastomosis often result in pelvic abscesses. 
The detection of this complication is possible using transrectal and transperineal US, although usually CT or 
MRI scanning is required the delineate the full extent of the complication.  Ultrasonography- or CT and -
guide drainage (297, 298). In this regard, pelvic abscess associated with anastomotic leak in patients with 
ileal pouch-anal anastomosis (IPAA) can be drained using either transanal or CT-guided approach. Both  are 
equally effective although there is a risk of fistula induction at drainage site after a CT-guided 
drainage(299). 
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WG7: Special situations nor emergencies: postsurgery, cancer surveillance, 
ileoanal pouch(150) 
 
 
 
 
 
29. US, CT,  MRI, SBFT and WBC scintigraphy detect recurrence of CD after ileocolonic resection and are 
complementary to endoscopy (EL:1, RG:B). 
US, CT,  MRI, SBFT and WBC scintigraphy can be useful as a follow-up method in patients after small 
bowel surgery (EL:1, RG:B). 
 
Recurrence of CD after surgical intervention is a diagnostically and therapeutically challenging condition. 
Several imaging modalities are available to reliably diagnose post surgical recurrence including ultrasound 
(US), SICUS, SBFT, CT enteroclysis or enterography (CTE) including virtual colonoscopy (VC), MR enteroclysis 
or MR enterography (MRE), SBCE and White Blood Cell Scintigraphy (WBC scintigraphy).  
Several authors had formerly emphasized the value of abdominal US in the postoperative follow-up and 
confirmed that the observation of the bowel wall thicking as an indicator for recurrence (300-303).. SICUS 
has  shown an excellent correlation with the endoscopic Rutgeerts' score (p = 0.0001; r = 0.67) reaching 
87.5% accuracy for detecting CD recurrence (304) and isconsidered to be superior to standard abdominal 
US in detecting postoperative CD recurrence after ileocecal resection (305).  Bowel wall thickening was 
defined by thickness of more than 3.5 mm. SICUS prediction of recurrence was found to be correct in 100% 
of cases and confirmed by endoscopy (305)These results were confirmed in two additional studies (306) 
(307) who determined sensitivity, specificity, positive and negative predictive values to be 61.5% (95% IC: 
41 79%), 96% (95% IC: 78 100%), 94%, and 71%, respectively. 
SBFT should only be used if cross-sectional imaging techniques are not available or very specific clinical 
questions apply. SBFT or enteroclysis is able to visualize the presence, extent and pattern of CD recurrence 
after ileo-colonic resection, although providing a radiation exposure to the patient(308). 
CT enterography or enteroclysis are an alternative to endoscopy for assessing postoperative recurrence of 
CD activity (309). Evidence for the value of CT enterography has also been shown. (310) . CT colonography 
has been tested for assessing the postoperative recurrence of CD with inconclusive results due to false 
negative findings. It does however  represent an alternative to conventional colonoscopy in noncompliant 
postsurgical patients with a rigid stenosis which do not allow passage of the endoscope (173) . 
MR enteroclysis or enterography may be an alternative to endoscopy as diagnostic tool in post-surgical 
recurrence evaluation in CD patients (140, 311). Similar to the endoscopic Rutgeerts´ score for assessing 
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post-surgical recurrence, one study showed an objective evaluation using an MRI based index of activity 
and severity for post-surgical recurrence. This score achieved a high correlation with the endoscopic index 
allowing differentiation between mild and severe lesions (312)  and predicting the risk of clinical post-
surgical recurrencein CD patients (313) . 
Although the Rutgeerts´ score has been used to evaluate the efficacy of several drugs, there is lack of 
information whether mural healing changes seen by cross-sectional imaging techniques are in parallel to 
the endoscopical mucosal healing. 
Scintigraphy with 99Tc-HMPAO or Indium 111 labeled leucocytes (or white blood cells WBC scintigraphy) 
has been reported as an alternative non-invasive technique for the detection of recurrence of intestinal 
inflammation in CD patients (314-317) . It is able to provide information about the localisation, extent and 
severity of a disease recurrence. Limitations of WBC scintigraphy are its relatively low specificity due to the 
high frequency of false positive findings (308). Investigations on the usefulness of WBC scintigraphy in 
assessing the early postoperative recurrence of CD are sparse (61, 138)  
 
 
30. Either Pelvic MRI  or CT are recommended in suspicion of septic complications [EL 3b, RG C] and/or  
CD of the pouch [EL 4, RG C] Pouchography can assess functional disorders, pouch strictures, afferent 
limb syndrome, pouch fistulae and pouch leakage. [EL:3b RG:C]. 
 
Ileo-anal (IA) pouch is a well-established option for patients who require surgery for chronic UC.  Despite 
excellent functional results the short and long-term outcome of ileal pouch with anal anastomosis (IPAA) is 
determined by the occurrence of complications. These may be directly related to the performed surgery or 
occur over the long-term. Immediate postsurgical complications include leakage, abscess formation, pelvic 
sepsis and fistula formation. More chronic disorders following IPAA are pouchitis, cuffitis, irritable pouch 
syndrome, pouch stricture, pouch sinus, afferent loop syndrome or small bowel obstruction (318). 
Recurrence of CD may occur within the pouch. Following surgery, up to 40% of patients have a single 
episode of pouchitis (319) within 12 months, a nonspecific inflammatory condition at the ileal pouch 
reservoir, whereas 19% to 5% experience intermittent episodes and chronic pouchitis, respectively (320-
322) . In addition to pouch endoscopy (PE), diagnostic imaging modalities are essential to help to 
distinguish inflammatory from non-inflammatory conditions and to identify extraluminal complications 
which require immediate interventions. 
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Therefore, cross-sectional imaging modalities such as CT- and MRE and MRI of the pelvis are key imaging 
modalities.  
Functional assessment of mechanical disorders related to the pouch such as pouch stricture, afferent loop 
syndrome and obstruction can be successfully addressed with functional radiographic techniques such as 
pouchography and defecography. The choice of the  most appropriate imaging modality depends on the 
clinically suspected disorder, local expertise and availability. Inflammatory and infectious complications are 
best addressed with CT and MRI. Despite a limited number of studies assessing the postoperative outcome 
of IPAA with these techniques, both CT and MRI are advocated to be useful in detecting mural 
inflammatory changes. In one study (323)  mural and extramural inflammatory lesions were found in 7 of 9 
patients with clinical suspicion of complicated IA pouch confirmed by histology. From these 7 patients, 2 
had normal mucosa at endoscopy. In another study a sensitivity of 78% and specificity of 96% for detecting 
IA pouch complications (fistula, abscess or pouchitis) was observed;  CT had a higher sensitivity than 
pouchography for the detection of inflammatory IPAA complications because extraluminal complications 
cannot readily be assessed with pouchography (324) . It is important to emphasize that transmural 
inflammation of the pouch detected on imaging is not necessarily due to CD, as it can also be seen in 
chronic pouchitis. it has been suggested  that asymmetric pouchitis may indicate ischemia in contrast to CD 
of the pouch or chronic pouchitis (325) . Transmural disease and wall thickening in the setting of IPAA is not 
pathognomonic of CD. Transmural inflammation shown by imaging or histopathology can be seen in both 
CD and chronic antibiotic-refractory pouchitis (326). 
Pelvic MRI can be used to assess recurrence of CD of pouch. Pelvic CT and MRI showed high accuracy for 
detecting IA inflammatory complications. Further larger series are needed to confirm their utility and 
determine whether cross sectional techniques may be helpful for differentiating pouchitis from CD 
recurrence. (EL3b). 
Barium-enhanced radiography (pouchography) is accepted for diagnosis of inflammatory complications of 
IA pouch as well as for non-inflammatory conditions (EL 3b). 
A correlation of CT, MRI, pouch endoscopy and retrograde pouchography findings with the clinical outcome 
and found a reasonable accuracy for diagnosis of strictures, fistulas, sinuses and pouch leaks with all 
methods (221) . CT had the lowest accurancy for small bowel strictures (74%), and MRI for pouch sinuses 
(68%). A Combination of 2 imaging tests increased the accurancy of diagnosis to 100%.  
The afferent limb syndrome, defined as the obstruction of afferent bowel loop at the junction of the pouch, 
can be diagnosed by imaging techniques (298); Barium enema or CT enterography can be used for the 
diagnosis of inflammatory or fibrostenotic CD of the pouch. Finally, it is important to emphasize that 
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transabdominal ultrasonography is poor at evaluatingIA pouch complications due to their typicallydeep 
location in the pelvis andinherent difficulty in visualization. 
 
 
31. CT colonography or virtual colonoscopy is not an alternative to colonoscopy in patients with proven 
IBD. However, it is useful to detect cancer in clinical situations where colonoscopy cannot be performed 
(e.g. strictures) (EL:2a; RG:B) 
 
There is no evidence that virtual colonoscopy by CT or MRI may be of utility for surveillance of colorectal 
cancer in patients with CD or UC. Considering the underlying inflammatory changes of the intestinal wall 
leading to permanent abdormalities such as pseudopolyps,  and the fact that a significant portion of 
dysplastic  lesions are flat at endoscopy, it is conceivable that with current cross-sectional imaging 
techniques both the number of false positive diagnosis and the miss-rate for these lesions would be high. 
Therefore, follow-up by periodical endoscopy including chromoendoscopy is recommended for screening 
of dysplasia at least for UC (327-329).  There are no specific trials for CD but epidemiological data suggest 
that patients with CD colitis have similar incidences of colorectal cancer as of patients with UC (330, 331). 
Therefore, in CD colitis a similar cancer surveillance algorithm should be applied. 
In patients with CD the risk for small bowel adenocarcinoma is increased with a relative risk up to 159 (332) 
. (333)A cumulative risks of 0.2% at 10 years and 2.2% at 25 years for CD patients with small bowel disease 
at diagnosis has been observed (334).(150) 
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